Agenda Chronic Liver Disease 2024
Saturday, March 16, 2024
7 a.m.
Registration, Breakfast & View Exhibits
8 a.m.
Welcome & Introduction
Paul J. Pockros, MD
8:15 a.m.
New Nomenclature for Steatotic Liver Disease
Paul J. Pockros, MD
8:45 a.m.
Diversity in MASH
Nadege Gunn, MD
9:30 a.m.
Incretins for Metabolic Liver Disease
Juan Pablo Frias, MD
10:15 a.m.
Break & View Exhibits
10:45 a.m.
Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists for MASH
Julio Gutierrez, MD
11:30 a.m.
Panel Discussion/Q&A
Noon
Lunch
Noon
Lunch Symposium
Non-CME Activity Hosted by AbbVie
1 p.m.
Colocalization of Addiction Medicine
Anthony Martinez, MD
1:30 p.m.
Emerging Therapies for Delta Hepatitis and Hepatitis B
Robert Gish, MD
2 p.m.
Cholestatic Liver Diseases
Kris Kowdley, MD
2:45 p.m.
Break & View Exhibits
3 p.m.
Alcohol Liver Disease
Raymond Lee, MD
3:30 p.m.
Management of Liver Masses
Adam Deising, DO
4 p.m.
Panel Discussion/Q&A
4:15 p.m.
Adjourn
4:15 p.m.
Velacur Interactive Showcase & Happy Hour
Non-CME Activity Hosted by Sonic Incytes
Next Generation Non-invasive Liver Assessment; Quantification of Liver Steatosis and Fibrosis
Kris Kowdley, MD
Sunday, March 17, 2024
7 a.m.
Breakfast & View Exhibits
7 a.m.
Breakfast Symposium
Non-CME Activity Hosted by Exelixis
An Exelixis Product for the Clinical Management of HCC
Mary Salazar, DNP, MSN, BSN, ANP-B
7:55 a.m.
Welcome & Announcements
Julio Gutierrez, MD
8 a.m.
Chronic Liver Disease and Liver Transplantation in Women
Gina Choi, MD
8:45 a.m.
Advances in the Treatment of HCC
Jennifer Au, MD
9:30 a.m.
Update of AASLD Guidelines on Portal Hypertension
Timothy Morgan, MD
10:15 a.m.
Break & View Exhibits
10:30 a.m.
WILLIAM S. HAUBRICH LECTURE: Renal Dysfunction in the Cirrhotic Patient
Paul Martin, MD
11:15 a.m.
Panel Discussion/Q&A
11:45 a.m.
Final Adjournment
**Topics, times, and speakers are subject to change